Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 5

Inflammation as a potential mediator for the association between periodontal disease and Alzheimer’s disease

Authors Amber Watts, Eileen M Crimmins, Margaret Gatz

Published 10 October 2008 Volume 2008:4(5) Pages 865—876


Review by Single-blind

Peer reviewer comments 2

Amber Watts1, Eileen M Crimmins1, Margaret Gatz2

1Davis School of Gerontology; 2Department of Psychology, University of Southern California, Los Angeles, CA, USA

Abstract: Periodontal disease (PDD) is associated with increased risk of cardiovascular disease, cerebrovascular disease, and mortality in many studies, while other studies have begun to suggest an association of PDD with Alzheimer’s disease (AD). This paper discusses how infectious pathogens and systemic infection may play a role in AD. The roles of infection and inflammation are addressed specifically with regard to known AD pathologic lesions including senile plaques, neuron death, neurofibrillary tangles, and cerebrovascular changes. A testable model of proposed pathways between periodontal infection and AD is presented including three possible mechanisms: a) direct effects of infectious pathogens, b) inflammatory response to pathogens, and c) the effects on vascular integrity. The role of gene polymorphisms is discussed, including apolipoprotein (APOE) ε4 as a pro-inflammatory and pro-infection genotype.

Keywords: periodontal disease, infection, inflammation, Alzheimer’s disease

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer

Huang H, Feng H, Qiao H, Ren Z, Zhu G

OncoTargets and Therapy 2015, 8:1157-1164

Published Date: 22 May 2015

Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals

Sun B, Li J, Shao D, Pan Y, Chen Y, Li S, Yao X, Li H, Liu W, Zhang M, Zhang X, Chen L

OncoTargets and Therapy 2015, 8:735-744

Published Date: 7 April 2015

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, Thomsen RW, Kjær A, Weis N

Vascular Health and Risk Management 2014, 10:55-62

Published Date: 21 January 2014

Acyclovir-resistant herpetic keratitis in a solid-organ transplant recipient on systemic immunosuppression

Turner LD, Beckingsale P

Clinical Ophthalmology 2013, 7:229-232

Published Date: 29 January 2013

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia

Ibrahim Turkoz, Cynthia A Bossie, Bryan Dirks, Carla M Canuso

Neuropsychiatric Disease and Treatment 2008, 4:949-958

Published Date: 10 October 2008

Brain ischemia and ischemic blood–brain barrier as etiological factors in sporadic Alzheimer’s disease

Ryszard Pluta, Marzena Utamek, Poland

Neuropsychiatric Disease and Treatment 2008, 4:855-864

Published Date: 10 October 2008

Traumatic brain injury: future assessment tools and treatment prospects

Steven R Flanagan, Joshua B Cantor, Teresa A Ashman

Neuropsychiatric Disease and Treatment 2008, 4:877-892

Published Date: 10 October 2008

The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats

Haris Carageorgiou, Antonios C Sideris, Ioanna Messari, Chrissoula I Liakou, Stylianos Tsakiris

Neuropsychiatric Disease and Treatment 2008, 4:687-699

Published Date: 8 August 2008

Cyclosporin-A associated malignancy

Jonathan M Durnian, Rosalind MK Stewart, Richard Tatham, Mark Batterbury, Stephen B Kaye

Clinical Ophthalmology 2007, 1:421-430

Published Date: 15 February 2008